154 related articles for article (PubMed ID: 17697601)
21. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.
Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
J Cancer Res Clin Oncol; 2010 Feb; 136(2):203-10. PubMed ID: 19657672
[TBL] [Abstract][Full Text] [Related]
22. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
23. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
[TBL] [Abstract][Full Text] [Related]
24. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
[TBL] [Abstract][Full Text] [Related]
25. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
26. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia.
Kang S; Kim J; Kim HB; Shim JW; Nam E; Kim SH; Ahn HJ; Choi YP; Ding B; Song K; Cho NH
Diagn Mol Pathol; 2006 Jun; 15(2):74-82. PubMed ID: 16778587
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.
Xue WC; Chan KY; Feng HC; Chiu PM; Ngan HY; Tsao SW; Cheung AN
J Mol Diagn; 2004 Nov; 6(4):326-34. PubMed ID: 15507671
[TBL] [Abstract][Full Text] [Related]
29. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.
Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M
Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185
[TBL] [Abstract][Full Text] [Related]
30. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
[TBL] [Abstract][Full Text] [Related]
31. Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.
Blanco-Luquin I; Guarch R; Ojer A; Pérez-Janices N; Martín-Sánchez E; Maria-Ruiz S; Monreal-Santesteban I; Blanco-Fernandez L; Pernaut-Leza E; Escors D; Guerrero-Setas D
Pathol Int; 2015 Sep; 65(9):476-85. PubMed ID: 26222671
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.
Lin HH; Ke HL; Wu WJ; Lee YH; Chang LL
Urol Oncol; 2012; 30(2):177-81. PubMed ID: 20800513
[TBL] [Abstract][Full Text] [Related]
34. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract][Full Text] [Related]
35. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
36. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
[TBL] [Abstract][Full Text] [Related]
39. [Quantitative detection of APC/RASSF1A promoter methylation in the plasma of patients with cervical diseases].
Wang H; Pan SY; Pang ZR; Wang F; Xu J; Chen D; Xie EF; Zhang LX; Gao L; Xu YQ; Jin B
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):929-34. PubMed ID: 24495688
[TBL] [Abstract][Full Text] [Related]
40. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]